DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in DiaMedica Therapeutics Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +5 vs. Q3 2021
- Shares held
- 4.00M
- +1.19M (+42.4%) vs. Q3 2021
- Total value
- $14.9M
- +$3.65M (+32.5%) vs. Q3 2021
- New holders
- 8
- 13 more added
- Sold out
- 3
- 7 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $87.8M |
| Q1 2026 | 99 | $79.2M |
| Q4 2025 | 92 | $96.0M |
| Q3 2025 | 78 | $82.8M |
| Q2 2025 | 58 | $34.2M |
| Q1 2025 | 57 | $28.5M |
| Q4 2024 | 45 | $36.5M |
| Q3 2024 | 40 | $23.3M |
| Q2 2024 | 32 | $14.9M |
| Q1 2024 | 32 | $12.7M |
| Q4 2023 | 38 | $10.9M |
| Q3 2023 | 36 | $11.0M |
| Q2 2023 | 32 | $15.1M |
| Q1 2023 | 25 | $3.93M |
| Q4 2022 | 28 | $3.99M |
| Q3 2022 | 26 | $3.14M |
| Q2 2022 | 28 | $7.42M |
| Q1 2022 | 34 | $10.0M |
| Q4 2021 | 39 | $14.9M |
| Q3 2021 | 34 | $11.2M |
| Q2 2021 | 43 | $16.9M |
| Q1 2021 | 41 | $52.1M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 24 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3 | $0 | 0.00% | +3 | New |
| FinTrust Capital Advisors, LLC | 75 | $0 | 0.00% | +75 | New |
| Federation des caisses Desjardins du Quebec | 230 | $858 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 162 | $1.00K | 0.00% | +47+40.9% | Added |
| Royal Bank of Canada | 805 | $3.00K | 0.00% | −1,500−65.1% | Reduced |
| Patriot Financial Group Insurance Agency, LLC | 1,300 | $4.00K | 0.00% | 00.0% | Unchanged |
| Sandy Cove Advisors, LLC | 1,200 | $4.00K | 0.00% | +1,200 | New |
| Newbridge Financial Services Group, Inc. | 1,510 | $6.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 1,840 | $8.33K | 0.00% | +1,840 | New |
| US Bancorp | 4,335 | $16.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,618 | $17.0K | 0.00% | +4,618 | New |
| Massmutual Trust Co FSB | 4,824 | $18.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 6,350 | $23.0K | 0.00% | −9,991−61.1% | Reduced |
| Tower Research Capital LLC (TRC) | 9,360 | $35.0K | 0.00% | +7,890+536.7% | Added |
| Shay Capital LLC | 10,000 | $37.0K | 0.01% | 00.0% | Unchanged |
| Marshall Wace, LLP | 10,031 | $38.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 11,900 | $44.0K | 0.00% | +11,900 | New |
| Susquehanna International Group, LLP | 14,065 | $52.0K | 0.00% | −46,364−76.7% | Reduced |
| Boothbay Fund Management, LLC | 20,603 | $77.0K | 0.00% | −10,301−33.3% | Reduced |
| Jump Financial, LLC | 21,800 | $81.0K | 0.01% | +3,500+19.1% | Added |
| Millennium Management LLC | 22,249 | $83.0K | 0.00% | +22,249 | New |
| Morgan Stanley | 23,900 | $89.0K | 0.00% | +12,500+109.6% | Added |
| Group One Trading, L.P. | 33,868 | $126.0K | 0.00% | +9,650+39.8% | Added |
| Bank of New York Mellon Corp | 49,884 | $186.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 58,572 | $219.0K | 0.00% | +2,602+4.6% | Added |
| State Street Corp | 59,717 | $223.0K | 0.00% | +20,000+50.4% | Added |
| Citadel Advisors LLC | 65,600 | $245.0K | 0.00% | +29,746+83.0% | Added |
| Northern Trust Corp | 101,283 | $378.0K | 0.00% | +15,713+18.4% | Added |
| Two Sigma Advisers, LP | 106,600 | $398.0K | 0.00% | +26,000+32.3% | Added |
| Anson Funds Management LP | 130,070 | $485.0K | 0.07% | +130,070 | New |
| Two Sigma Investments, LP | 140,857 | $525.0K | 0.00% | +66,577+89.6% | Added |
| Manatuck Hill Partners, LLC | 144,800 | $540.0K | 0.20% | −128,300−47.0% | Reduced |
| Geode Capital Management, LLC | 167,763 | $625.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 209,082 | $779.0K | 0.22% | −101,959−32.8% | Reduced |
| Jacob Asset Management of New York LLC | 275,000 | $1.03M | 0.46% | 00.0% | Unchanged |
| Cooperman Leon G | 300,000 | $1.12M | 0.06% | +100,000+50.0% | Added |
| Vanguard Group Inc | 786,552 | $2.93M | 0.00% | −984−0.1% | Reduced |
| Stonepine Capital Management, LLC | 1,194,670 | $4.46M | 2.04% | +1,028,895+620.7% | Added |
| Barclays PLC | 0 | $0 | 0.00% | −4,616−100.0% | Sold out |
| Gables Capital Management Inc. | 0 | $0 | 0.00% | −542−100.0% | Sold out |
| Gerber Kawasaki Wealth & Investment Management | 0 | $0 | 0.00% | −197−100.0% | Sold out |